Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of Chicago, shared on X:
“Does the blast percentage in NPM1m mutated myeloid malignancies matter? Some publications supporting that the disease behaves like AML even when blasts < 20%.”.
Read further.
Source: Anand Patel/X
